This was in line with HO-1 levels in plasma, which were significantly elevated in STEC-HUS patients with median (range) of 163 (2.57–789) ng/ml compared to 23.7 (6–70) ng/ml in healthy controls (p < 0.001). The gene discussed is HMOX1; the disease is hemolytic-uremic syndrome.